The interleukin 23 (IL-23) has emerged as a key pro-inflammatory cytokine involved in the development of chronic inflammatory diseases, such as psoriasis, inflammatory bowel diseases, multiple sclerosis, or rheumatoid arthritis in murine models [1] and, more importantly, in humans. Here, IL37 is linked to psoriasis.